— Know what they know.
Not Investment Advice

TPTX NASDAQ

Turning Point Therapeutics, Inc.
1W: +1.3% 1M: +1.6% 3M: +134.0% 1Y: +13.9% 3Y: +79.2%
$75.49
Last traded 2022-08-16 — delisted
NASDAQ · Healthcare · Biotechnology

Balance Sheet Trends

Total Assets
$1.0B -11.7% ▼
4Y CAGR: +116.2%
Total Liabilities
$49M +82.9% ▲
4Y CAGR: -8.8%
Shareholders Equity
$954M -14.0% ▼
Cash & Investments
$982M -12.6% ▼
4Y CAGR: +116.1%
Total Debt
$6M +46.1% ▲
Net Debt
-$422M +23.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2017FY2018FY2019FY2020FY2021
— Assets —
Cash$45M$101M$48M$554M$428M
Short-Term Investments$0$0$361M$568M$554M
Cash & ST Investments$45M$101M$409M$1.1B$982M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$581K$494K$6M$8M$11M
Total Current Assets$46M$102M$415M$1.1B$992M
Property, Plant & Equip.$256K$1M$7M$6M$9M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$38K$757K$73K$73K$2M
Total Non-Current Assets$294K$2M$7M$6M$11M
Total Assets$46M$103M$422M$1.1B$1.0B
— Liabilities —
Accounts Payable$1M$1M$2M$5M$6M
Short-Term Debt$0$0$1M$1M$4M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$3M$4M$11M$18M$38M
Total Current Liabilities$5M$5M$14M$24M$47M
Long-Term Debt$0$0$4M$2M$2M
Other Non-Current Liab.$66M$448K$0$0$0
Total Non-Current Liabilities$66M$448K$4M$2M$2M
Total Liabilities$71M$6M$18M$27M$49M
— Equity —
Common Stock$1K$2K$4K$5K$5K
Retained Earnings-$26M-$51M-$123M-$280M-$517M
Accumulated OCI-$136K-$271K$271K$209K-$1M
Total Stockholders Equity-$25M$98M$404M$1.1B$954M
Total Liabilities & Equity$46M$103M$422M$1.1B$1.0B
— Key Metrics —
Total Debt$0$0$5M$4M$6M
Net Debt-$45M-$101M-$43M-$550M-$422M
Total Investments$0$0$361M$568M$554M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms